{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:10:16Z","timestamp":1771488616909,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Sanming Project of Medicine in Shenzhen, China","award":["No. SZSM201911020"],"award-info":[{"award-number":["No. SZSM201911020"]}]},{"name":"the Sanming Project of Medicine in Shenzhen, China","award":["No. SZSM201911020"],"award-info":[{"award-number":["No. SZSM201911020"]}]},{"name":"the Sanming Project of Medicine in Shenzhen, China","award":["No. SZSM201911020"],"award-info":[{"award-number":["No. SZSM201911020"]}]},{"name":"the Sanming Project of Medicine in Shenzhen, China","award":["No. SZSM201911020"],"award-info":[{"award-number":["No. SZSM201911020"]}]},{"name":"the Sanming Project of Medicine in Shenzhen, China","award":["No. SZSM201911020"],"award-info":[{"award-number":["No. SZSM201911020"]}]},{"name":"the Sanming Project of Medicine in Shenzhen, China","award":["No. SZSM201911020"],"award-info":[{"award-number":["No. SZSM201911020"]}]},{"name":"the Sanming Project of Medicine in Shenzhen, China","award":["No. SZSM201911020"],"award-info":[{"award-number":["No. SZSM201911020"]}]},{"name":"the Sanming Project of Medicine in Shenzhen, China","award":["No. SZSM201911020"],"award-info":[{"award-number":["No. SZSM201911020"]}]},{"name":"the Sanming Project of Medicine in Shenzhen, China","award":["No. SZSM201911020"],"award-info":[{"award-number":["No. SZSM201911020"]}]},{"name":"High Level-Hospital Program, Health Commission of Guangdong Province, China","award":["No. HKUSZH201901001"],"award-info":[{"award-number":["No. HKUSZH201901001"]}]},{"name":"High Level-Hospital Program, Health Commission of Guangdong Province, China","award":["No. HKUSZH201901001"],"award-info":[{"award-number":["No. HKUSZH201901001"]}]},{"name":"High Level-Hospital Program, Health Commission of Guangdong Province, China","award":["No. HKUSZH201901001"],"award-info":[{"award-number":["No. HKUSZH201901001"]}]},{"name":"High Level-Hospital Program, Health Commission of Guangdong Province, China","award":["No. HKUSZH201901001"],"award-info":[{"award-number":["No. HKUSZH201901001"]}]},{"name":"High Level-Hospital Program, Health Commission of Guangdong Province, China","award":["No. HKUSZH201901001"],"award-info":[{"award-number":["No. HKUSZH201901001"]}]},{"name":"High Level-Hospital Program, Health Commission of Guangdong Province, China","award":["No. HKUSZH201901001"],"award-info":[{"award-number":["No. HKUSZH201901001"]}]},{"name":"High Level-Hospital Program, Health Commission of Guangdong Province, China","award":["No. HKUSZH201901001"],"award-info":[{"award-number":["No. HKUSZH201901001"]}]},{"name":"High Level-Hospital Program, Health Commission of Guangdong Province, China","award":["No. HKUSZH201901001"],"award-info":[{"award-number":["No. HKUSZH201901001"]}]},{"name":"High Level-Hospital Program, Health Commission of Guangdong Province, China","award":["No. HKUSZH201901001"],"award-info":[{"award-number":["No. HKUSZH201901001"]}]},{"name":"HKU-SZH Fund for Shenzhen Key Medical Discipline","award":["No. SZXK2020081"],"award-info":[{"award-number":["No. SZXK2020081"]}]},{"name":"HKU-SZH Fund for Shenzhen Key Medical Discipline","award":["No. SZXK2020081"],"award-info":[{"award-number":["No. SZXK2020081"]}]},{"name":"HKU-SZH Fund for Shenzhen Key Medical Discipline","award":["No. SZXK2020081"],"award-info":[{"award-number":["No. SZXK2020081"]}]},{"name":"HKU-SZH Fund for Shenzhen Key Medical Discipline","award":["No. SZXK2020081"],"award-info":[{"award-number":["No. SZXK2020081"]}]},{"name":"HKU-SZH Fund for Shenzhen Key Medical Discipline","award":["No. SZXK2020081"],"award-info":[{"award-number":["No. SZXK2020081"]}]},{"name":"HKU-SZH Fund for Shenzhen Key Medical Discipline","award":["No. SZXK2020081"],"award-info":[{"award-number":["No. SZXK2020081"]}]},{"name":"HKU-SZH Fund for Shenzhen Key Medical Discipline","award":["No. SZXK2020081"],"award-info":[{"award-number":["No. SZXK2020081"]}]},{"name":"HKU-SZH Fund for Shenzhen Key Medical Discipline","award":["No. SZXK2020081"],"award-info":[{"award-number":["No. SZXK2020081"]}]},{"name":"HKU-SZH Fund for Shenzhen Key Medical Discipline","award":["No. SZXK2020081"],"award-info":[{"award-number":["No. SZXK2020081"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Aims<\/jats:title>\n            <jats:p>The present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their interaction on the Left Ventricle (LV) structure and diastolic function in type 2 diabetes mellitus (T2DM) patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A total of 595 T2DM patients were recruited and stratified according to NFS grades (low, intermediate, and high) and the level of serum 25(OH)D (with and without vitamin D deficiency). Parameters of LV structure and diastolic dysfunction were measured by echocardiography. The association between NFS and LV structure and diastolic function was assessed using multivariable linear regression models stratified by vitamin D levels.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Left ventricular hypertrophy (LVH) was more prevalent in patients with high NFS compared to those with low and intermediate NFS (41.0 vs 14.0% and 9.0%, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The average E\/e\u2032 was higher in patients with intermediate and high NFS, as compared to those with low NFS. Within the high NFS group, patients with vitamin D deficiency exhibited significantly higher left ventricular mass index (LVMI) and average E\/e\u2032 compared to those without vitamin D deficiency. An interaction between vitamin D and NFS groups was found on both LVMI (<jats:italic>P<\/jats:italic> for interaction\u2009=\u20090.008) and average E\/e\u2032 (<jats:italic>P<\/jats:italic> for interaction\u2009=\u20090.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>NFS and vitamin D deficiency are associated with an increased risk of LVH and impaired diastolic function in patients with T2DM. Notably, the impact of vitamin D deficiency on these parameters is more pronounced in individuals with a high NFS score.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13098-025-01808-3","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T06:10:15Z","timestamp":1754028615000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Interaction between the non-alcoholic fatty liver disease fibrosis score and vitamin D deficiency on left ventricular hypertrophy and impaired diastolic function in patients with type 2 diabetes mellitus"],"prefix":"10.1186","volume":"17","author":[{"given":"Yun-Ming","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Run","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Ya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Hang","family":"Yiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"1808_CR1","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.2337\/diacare.27.8.1879","volume":"27","author":"GA Nichols","year":"2004","unstructured":"Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB. The incidence of congestive heart failure in type 2 diabetes: an update. Diab Care. 2004;27:1879\u201384.","journal-title":"Diab Care"},{"key":"1808_CR2","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s00125-005-1896-y","volume":"48","author":"A Dawson","year":"2005","unstructured":"Dawson A, Morris AD, Struthers AD. The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus. Diabetologia. 2005;48:1971\u20139.","journal-title":"Diabetologia"},{"key":"1808_CR3","doi-asserted-by":"crossref","unstructured":"Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diab care. 2001;24.","DOI":"10.2337\/diacare.24.1.5"},{"key":"1808_CR4","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1161\/CIRCULATIONAHA.110.955542","volume":"122","author":"ACT Ng","year":"2010","unstructured":"Ng ACT, Delgado V, Bertini M, van der Meer RW, Rijzewijk LJ, Hooi Ewe S, et al. Myocardial steatosis and biventricular strain and strain rate imaging in patients with type 2 diabetes mellitus. Circulation. 2010;122:2538\u201344.","journal-title":"Circulation"},{"key":"1808_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14:88\u201398.","journal-title":"Nat Rev Endocrinol"},{"key":"1808_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73\u201384.","journal-title":"Hepatology"},{"key":"1808_CR7","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Golabi P, de Avila L, Paik JM, Srishord M, Fukui N, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019;71:793\u2013801.","journal-title":"J Hepatol"},{"key":"1808_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","volume":"65","author":"G Targher","year":"2016","unstructured":"Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol. 2016;65:589\u2013600.","journal-title":"J Hepatol"},{"key":"1808_CR9","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM. Non-alcoholic fatty liver disease\u2014a global public health perspective. J Hepatol. 2019;70:531\u201344.","journal-title":"J Hepatol"},{"key":"1808_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11892-021-01383-7","volume":"21","author":"C Caussy","year":"2021","unstructured":"Caussy C, Aubin A, Loomba R. The relationship between type 2 diabetes, NAFLD, and cardiovascular risk. Curr Diab Rep. 2021;21:15.","journal-title":"Curr Diab Rep"},{"key":"1808_CR11","doi-asserted-by":"crossref","unstructured":"Siddiqui MS, Yamada G, Vuppalanchi R, Van Natta M, Loomba R, Guy C et al. Diagnostic accuracy of noninvasive fibrosis models to detect change in fibrosis stage. Clin Gastroenterol Hepatol. 2019;17.","DOI":"10.1016\/j.cgh.2018.12.031"},{"key":"1808_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4093\/dmj.2019.0001","volume":"44","author":"H Lee","year":"2020","unstructured":"Lee H, Kim G, Choi YJ, Huh BW, Lee BW, Kang ES, et al. Association between non-alcoholic steatohepatitis and left ventricular diastolic dysfunction in type 2 diabetes mellitus. Diab Metab J. 2020;44:267\u201376.","journal-title":"Diab Metab J"},{"key":"1808_CR13","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.jhep.2017.11.023","volume":"68","author":"Y-H Lee","year":"2018","unstructured":"Lee Y-H, Kim KJ, Yoo ME, Kim G, Yoon H-J, Jo K, et al. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients. J Hepatol. 2018;68:764\u201372.","journal-title":"J Hepatol"},{"key":"1808_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.atherosclerosis.2018.03.027","volume":"272","author":"GE Chung","year":"2018","unstructured":"Chung GE, Lee J-H, Lee H, Kim MK, Yim JY, Choi S-Y, et al. Nonalcoholic fatty liver disease and advanced fibrosis are associated with left ventricular diastolic dysfunction. Atherosclerosis. 2018;272:137\u201344.","journal-title":"Atherosclerosis"},{"key":"1808_CR15","first-page":"123","volume":"42","author":"R Hidayat","year":"2010","unstructured":"Hidayat R, Setiati S, Soewondo P. The association between vitamin D deficiency and type 2 diabetes mellitus in elderly patients. Acta Med Indones. 2010;42:123\u20139.","journal-title":"Acta Med Indones"},{"key":"1808_CR16","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2147\/DMSO.S203700","volume":"12","author":"H Darraj","year":"2019","unstructured":"Darraj H, Badedi M, Poore KR, Hummadi A, Khawaji A, Solan Y, et al. Vitamin D deficiency and glycemic control among patients with type 2 diabetes mellitus in Jazan City, Saudi Arabia. Diab Metab Syndr Obes Targets Therapy. 2019;12:853\u201362.","journal-title":"Diab Metab Syndr Obes Targets Therapy"},{"key":"1808_CR17","doi-asserted-by":"publisher","first-page":"564738","DOI":"10.3389\/fendo.2020.564738","volume":"11","author":"Y Xiao","year":"2020","unstructured":"Xiao Y, Wei L, Xiong X, Yang M, Sun L. Association between vitamin D status and diabetic complications in patients with type 2 diabetes mellitus: a cross-sectional study in Hunan China. Front Endocrinol. 2020;11:564738.","journal-title":"Front Endocrinol"},{"key":"1808_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/joim.12007","volume":"273","author":"P Ameri","year":"2013","unstructured":"Ameri P, Canepa M, Milaneschi Y, Spallarossa P, Leoncini G, Giallauria F, et al. Relationship between vitamin D status and left ventricular geometry in a healthy population: results from the Baltimore Longitudinal Study of Aging. J Intern Med. 2013;273:253\u201362.","journal-title":"J Intern Med"},{"key":"1808_CR19","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1177\/1479164113491125","volume":"10","author":"O Kulo\u011flu","year":"2013","unstructured":"Kulo\u011flu O, G\u00fcr M, \u015eeker T, Kalkan GY, K\u0131r\u0131m S, \u015eahin DY, et al. Serum 25-hydroxyvitamin D level is associated with aortic distensibility and left ventricle hypertrophy in newly diagnosed type 2 diabetes mellitus. Diab Vasc Dis Res. 2013;10:546\u20139.","journal-title":"Diab Vasc Dis Res"},{"key":"1808_CR20","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.2147\/DMSO.S299422","volume":"14","author":"L Xiu","year":"2021","unstructured":"Xiu L, Yao X-A, Jiang T. Correlation between 25-hydroxyvitamin D level and cardiac diastolic dysfunction in chinese adults with early-onset type 2 diabetes mellitus: a cross-sectional study. Diab Metab Syndr Obes Targets Therapy. 2021;14:1823\u201331.","journal-title":"Diab Metab Syndr Obes Targets Therapy"},{"key":"1808_CR21","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jdiacomp.2014.01.003","volume":"28","author":"Y Chen","year":"2014","unstructured":"Chen Y, Zhao C-T, Zhen Z, Wong A, Tse HF, Yiu KH. Association of myocardial dysfunction with vitamin D deficiency in patients with type 2 diabetes mellitus. J Diab Compl. 2014;28:286\u201390.","journal-title":"J Diab Compl"},{"key":"1808_CR22","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diab Med. 1998;15:539\u201353.","journal-title":"Diab Med"},{"key":"1808_CR23","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1080\/08037051.2018.1527177","volume":"27","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Blood Press. 2018;27:314\u201340.","journal-title":"Blood Press"},{"key":"1808_CR24","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45:846\u201354.","journal-title":"Hepatology"},{"key":"1808_CR25","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/s41430-020-0558-y","volume":"74","author":"K Amrein","year":"2020","unstructured":"Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, K\u00f6stenberger M, Tmava Berisha A, et al. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr. 2020;74:1498\u2013513.","journal-title":"Eur J Clin Nutr"},{"key":"1808_CR26","doi-asserted-by":"crossref","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28.","DOI":"10.1016\/j.echo.2014.10.003"},{"key":"1808_CR27","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1161\/01.CIR.55.4.613","volume":"55","author":"RB Devereux","year":"1977","unstructured":"Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977;55:613\u20138.","journal-title":"Circulation"},{"key":"1808_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","volume":"29","author":"SF Nagueh","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29:277\u2013314.","journal-title":"J Am Soc Echocardiogr"},{"key":"1808_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.atherosclerosis.2015.05.002","volume":"241","author":"Y Chen","year":"2015","unstructured":"Chen Y, Xu M, Wang T, Sun J, Sun W, Xu B, et al. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease. Atherosclerosis. 2015;241:145\u201350.","journal-title":"Atherosclerosis"},{"key":"1808_CR30","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/hep.26156","volume":"57","author":"D Kim","year":"2013","unstructured":"Kim D, Kim WR, Kim HJ, Therneau TM. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology. 2013;57:1357\u201365.","journal-title":"Hepatology"},{"key":"1808_CR31","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1111\/jgh.15387","volume":"36","author":"HS Chun","year":"2021","unstructured":"Chun HS, Lee JS, Lee HW, Kim BK, Park JY, Kim DY, et al. Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes. J Gastroenterol Hepatol. 2021;36:1703\u201313.","journal-title":"J Gastroenterol Hepatol"},{"key":"1808_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.atherosclerosis.2020.03.010","volume":"299","author":"Q Chen","year":"2020","unstructured":"Chen Q, Li Q, Li D, Chen X, Liu Z, Hu G, et al. Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease. Atherosclerosis. 2020;299:45\u201352.","journal-title":"Atherosclerosis"},{"key":"1808_CR33","doi-asserted-by":"publisher","first-page":"e0157517","DOI":"10.1371\/journal.pone.0157517","volume":"11","author":"MT Long","year":"2016","unstructured":"Long MT, Pedley A, Massaro JM, Hoffmann U, Fox CS. The association between non-invasive hepatic fibrosis markers and cardiometabolic risk factors in the Framingham Heart Study. PLoS ONE. 2016;11:e0157517.","journal-title":"PLoS ONE"},{"key":"1808_CR34","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/jdi.13430","volume":"12","author":"N Fan","year":"2021","unstructured":"Fan N, Ding X, Zhen Q, Gu L, Zhang A, Shen T, et al. Association of the non-alcoholic fatty liver disease fibrosis score with subclinical myocardial remodeling in patients with type 2 diabetes: a cross-sectional study in China. J Diabetes Investig. 2021;12:1035\u201341.","journal-title":"J Diabetes Investig"},{"key":"1808_CR35","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1093\/eurheartj\/ehab809","volume":"43","author":"A Zhou","year":"2022","unstructured":"Zhou A, Selvanayagam JB, Hypp\u00f6nen E. Non-linear Mendelian randomization analyses support a role for vitamin D deficiency in cardiovascular disease risk. Eur Heart J. 2022;43:1731\u20139.","journal-title":"Eur Heart J"},{"key":"1808_CR36","doi-asserted-by":"crossref","unstructured":"Al Mheid I, Quyyumi AA. Vitamin D and cardiovascular disease: controversy unresolved. J Am Coll Cardiol. 2017;70.","DOI":"10.1016\/j.jacc.2017.05.031"},{"key":"1808_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11883-017-0637-2","volume":"19","author":"K Chin","year":"2017","unstructured":"Chin K, Appel LJ, Michos ED. Vitamin D, calcium, and cardiovascular disease: A\u201cD\u201dvantageous or \u201cD\u201detrimental? An era of uncertainty. Curr Atheroscler Rep. 2017;19:5.","journal-title":"Curr Atheroscler Rep"},{"issue":"37","key":"1808_CR38","first-page":"357","volume":"2013","author":"D Gao","year":"2005","unstructured":"Gao D, Trayhurn P, Bing C. 1,25-Dihydroxyvitamin D3 inhibits the cytokine-induced secretion of MCP-1 and reduces monocyte recruitment by human preadipocytes. Int J Obes. 2005;2013(37):357\u201365.","journal-title":"Int J Obes"},{"key":"1808_CR39","doi-asserted-by":"publisher","first-page":"e58808","DOI":"10.1371\/journal.pone.0058808","volume":"8","author":"B Li","year":"2013","unstructured":"Li B, Baylink DJ, Deb C, Zannetti C, Rajaallah F, Xing W, et al. 1,25-Dihydroxyvitamin D3 suppresses TLR8 expression and TLR8-mediated inflammatory responses in monocytes in vitro and experimental autoimmune encephalomyelitis in vivo. PLoS ONE. 2013;8:e58808.","journal-title":"PLoS ONE"},{"key":"1808_CR40","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/hep.24737","volume":"55","author":"CL Roth","year":"2012","unstructured":"Roth CL, Elfers CT, Figlewicz DP, Melhorn SJ, Morton GJ, Hoofnagle A, et al. Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation. Hepatology. 2012;55:1103\u201311.","journal-title":"Hepatology"},{"key":"1808_CR41","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/ajg.2016.51","volume":"111","author":"JE Nelson","year":"2016","unstructured":"Nelson JE, Roth CL, Wilson LA, Yates KP, Aouizerat B, Morgan-Stevenson V, et al. Vitamin D deficiency is associated with increased risk of non-alcoholic steatohepatitis in adults with non-alcoholic fatty liver disease: possible role for MAPK and NF-\u03baB? Am J Gastroenterol. 2016;111:852\u201363.","journal-title":"Am J Gastroenterol"},{"key":"1808_CR42","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/hep.26390","volume":"58","author":"RM Kwok","year":"2013","unstructured":"Kwok RM, Torres DM, Harrison SA. Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association? Hepatology. 2013;58:1166\u201374.","journal-title":"Hepatology"},{"key":"1808_CR43","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/bonekey.2013.214","volume":"3","author":"R Bouillon","year":"2014","unstructured":"Bouillon R, Suda T. Vitamin D: calcium and bone homeostasis during evolution. Bonekey Rep. 2014;3:480.","journal-title":"Bonekey Rep"},{"key":"1808_CR44","doi-asserted-by":"publisher","first-page":"992666","DOI":"10.3389\/fendo.2022.992666","volume":"13","author":"I Portales-Castillo","year":"2022","unstructured":"Portales-Castillo I, Simic P. PTH, FGF-23, Klotho and vitamin D as regulators of calcium and phosphorus: genetics, epigenetics and beyond. Front Endocrinol. 2022;13:992666.","journal-title":"Front Endocrinol"},{"key":"1808_CR45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1172\/JCI0215219","volume":"110","author":"YC Li","year":"2002","unstructured":"Li YC, Kong J, Wei M, Chen Z-F, Liu SQ, Cao L-P. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Investig. 2002;110:229\u201338.","journal-title":"J Clin Investig"},{"key":"1808_CR46","doi-asserted-by":"crossref","unstructured":"Szymczak-Pajor I, \u015aliwi\u0144ska A. Analysis of association between vitamin D deficiency and insulin resistance. Nutrients. 2019;11.","DOI":"10.3390\/nu11040794"},{"key":"1808_CR47","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.dsx.2018.03.011","volume":"12","author":"SM Barbalho","year":"2018","unstructured":"Barbalho SM, Tofano RJ, de Campos AL, Rodrigues AS, Quesada K, Bechara MD, et al. Association between vitamin D status and metabolic syndrome risk factors. Diab Metab Syndr. 2018;12:501\u20137.","journal-title":"Diab Metab Syndr"},{"key":"1808_CR48","doi-asserted-by":"crossref","unstructured":"Melguizo-Rodr\u00edguez L, Costela-Ruiz VJ, Garc\u00eda-Recio E, De Luna-Bertos E, Ruiz C, Illescas-Montes R. Role of vitamin D in the metabolic syndrome. Nutrients. 2021;13.","DOI":"10.3390\/nu13030830"},{"key":"1808_CR49","doi-asserted-by":"crossref","unstructured":"de las Fuentes L, Waggoner AD, Mohammed BS, Stein RI, Miller BV, Foster GD et al. Effect of moderate diet-induced weight loss and weight regain on cardiovascular structure and function. J Am Coll Cardiol. 2009;54:2376\u201381.","DOI":"10.1016\/j.jacc.2009.07.054"},{"key":"1808_CR50","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1253\/circj.CJ-12-0722","volume":"76","author":"S Warita","year":"2012","unstructured":"Warita S, Kawasaki M, Tanaka R, Ono K, Kojima T, Hirose T, et al. Effects of pitavastatin on cardiac structure and function and on prevention of atrial fibrillation in elderly hypertensive patients: a prospective study of 2-years\u2019 follow-up. Circ J. 2012;76:2755\u201362.","journal-title":"Circ J"},{"key":"1808_CR51","doi-asserted-by":"crossref","unstructured":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81(3):492\u2013542.","DOI":"10.1016\/j.jhep.2024.04.031"},{"issue":"5","key":"1808_CR52","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s11739-022-02966-2","volume":"17","author":"A Sonaglioni","year":"2022","unstructured":"Sonaglioni A, Cerini F, Cerrone A, et al. Liver stiffness measurement identifies subclinical myocardial dysfunction in non-advanced non-alcoholic fatty liver disease patients without overt heart disease. Intern Emerg Med. 2022;17(5):1425\u201338.","journal-title":"Intern Emerg Med"},{"issue":"6","key":"1808_CR53","doi-asserted-by":"publisher","first-page":"oead108","DOI":"10.1093\/ehjopen\/oead108","volume":"3","author":"K Hirose","year":"2023","unstructured":"Hirose K, Nakanishi K, Di Tullio MR, et al. Association between non-alcoholic fatty liver disease and subclinical left ventricular dysfunction in the general population. Eur Heart J Open. 2023;3(6):oead108.","journal-title":"Eur Heart J Open"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01808-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-025-01808-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01808-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T10:49:29Z","timestamp":1757328569000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-025-01808-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1808"],"URL":"https:\/\/doi.org\/10.1186\/s13098-025-01808-3","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"13 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the principles of the Declaration of Helsinki and was approved by the ethics committee of the University of Hong Kong Shenzhen Hospital, Shenzhen, China. Informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"307"}}